Ticker
NVO
Valuation
Valuation for Novo Nordisk A/s Class B (NVO) on 6ix covers company data, market context, news, risks, and AI research briefs.
Novo Nordisk A/s Class B investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to NVO.
NVO
Stock
$190.45B
Health Technology
Pharmaceuticals: Major
USD
Novo Nordisk A/s Class B may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.
Review valuation context for Novo Nordisk A/s Class B.
Review future growth context for Novo Nordisk A/s Class B.
Review past performance context for Novo Nordisk A/s Class B.
Review financial health context for Novo Nordisk A/s Class B.
Review dividend context for Novo Nordisk A/s Class B.
Review management context for Novo Nordisk A/s Class B.
Review ownership context for Novo Nordisk A/s Class B.
Review other information context for Novo Nordisk A/s Class B.
Review community context for Novo Nordisk A/s Class B.